| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f292a0107b7bccbe79262781e1bf30a7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 |
| filingDate |
1988-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1989-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f8b37f9ba5e5322c2d28514ae57464d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15ca8061560c5f614a1424dc14b6aedc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1feaf9c43422b8cef11450b5aa01adb2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99803fc74c3d5bf863c45e2f9ce5c3ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ed7e7c2db7d9178a16b5caa0d177fe7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf49783fd545ea9c310c8355aca83c66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cb4b61bc1d72173eb98a2b34d29f7fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a550b0e9fd7d9254b1ecb5015a35c710
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0da6810b333c185e4adbbdb3743b451c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbc0ca3da410815aad6c10274e04209c |
| publicationDate |
1989-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4871728-A |
| titleOfInvention |
Pharmaceutical composition comprising an organic zinc complex and a process for preparing the active substance |
| abstract |
The invention refers to a novel pharmaceutical composition having especially antimycotic activity and comprising the zinc complex of 5-chloro-7-iodo-8-hydroxyquinoline of formula (I) <IMAGE> (I) and one or more pharmaceutically acceptable carriers. The pharmaceutical composition of the invention can be used for the effective treatment of mycotic infections on the skin surface, mucous membranes or nails. The complex of formula (I) is prepared by reacting a solution of an alkali metal salt of 5-chloro-7-iodo-8-hydroxyquinoline with a solution containing an excess of an inorganic or organic zinc salt or a zinc complex having a lower stability constant than that of the complex of formula (I) and separating the product precipitated. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9919175-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013264509-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5219847-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016030792-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9089730-B2 |
| priorityDate |
1986-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |